Bilal Muhsin on clinical decision support
From Interview with Bilal Muhsin, COO, Masimo - Arab Health 2025 · · WHX Dubai
“Whether it's our clinical decision support related to sepsis or just a deterioration score, we can really help clinicians and guide them hopefully to see things before they notice it as well with their patients.”
On , Bilal Muhsin, Chief Operating Officer at MASIMO CORP, spoke about clinical decision support during Interview with Bilal Muhsin, COO, Masimo - Arab Health 2025 on WHX Dubai.
About Bilal Muhsin
Bilal Muhsin, Chief Operating Officer at Masimo, discussed the company's focus on artificial intelligence and wearable technology in interviews at the Arab Health exhibition in 2022 and 2025. In 2022, he highlighted the launch of new connected care platforms and the W1 wearable watch, describing the Middle East as a large market focused on advancing care through innovation and automation. He noted that Arab Health was the company's largest global show and that the event allowed Masimo to meet with ministries of health and key hospitals. In 2025, Muhsin stated that Masimo is "heavily invested" in AI technologies, beginning with wearable sensing to acquire physiological signals for analysis. He described the company's clinical decision support tools for sepsis and deterioration scores, as well as a "safety net system" that provides real-time AI analysis of continuous patient data. Muhsin said the system can explain the reasons behind AI decisions and recommend actions for clinicians. He characterized Arab Health as a very important event for the company and the largest medical show Masimo attends, providing exposure beyond the Middle East.